Akonni Biosystems
Molecular diagnostics developing and marketing integrated molecular diagnostic systems.
Launch date
Employees
Market cap
-
Enterprise valuation
€15—22m (Dealroom.co estimates May 2017.)
Frederick Maryland (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| $2.2m | Series A | |
| N/A | $450k | Grant | |
| N/A | $6.0m | Series B | |
| N/A | $5.0m | Debt | |
$400k | Grant | ||
$3.0m | Grant | ||
| N/A | $910k | Early VC | |
$300k | Grant | ||
| N/A | $2.1m | Early VC | |
$25.0m | Series C | ||
$300k | Grant | ||
| N/A | $620k | Late VC | |
| N/A | $1.3m | Debt | |
* | $4.0m | Series D | |
| Total Funding | €41.2m | ||
Related Content
Recent News about Akonni Biosystems
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.